将脂肪酸酰胺水解酶（FAAH）抑制与过氧化物酶体增殖物激活受体（PPAR）激活相结合：一种治疗阿尔茨海默病的新的潜在多靶点治疗策略。 - Suppr

Suppr

超能文献

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer's disease.

作者信息

Brunetti Leonardo, Laghezza Antonio, Loiodice Fulvio, Tortorella Paolo, Piemontese Luca

机构信息

Dipartimento di Farmacia - Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Bari, Italy.

出版信息

Neural Regen Res. 2020 Jan;15(1):67-68. doi: 10.4103/1673-5374.264458.

DOI:10.4103/1673-5374.264458

PMID:31535650

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6862411/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9122/6862411/7ca443885b12/NRR-15-67-g001.jpg

相似文献

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer's disease.

Neural Regen Res. 2020 Jan;15(1):67-68. doi: 10.4103/1673-5374.264458.

New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation.

J Med Chem. 2019 Dec 26;62(24):10995-11003. doi: 10.1021/acs.jmedchem.9b00885. Epub 2019 Aug 22.

A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).

Molecules. 2022 Jan 31;27(3):958. doi: 10.3390/molecules27030958.

Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.

Psychopharmacology (Berl). 2018 Nov;235(11):3211-3221. doi: 10.1007/s00213-018-5020-7. Epub 2018 Sep 24.

Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells.

Cells. 2019 May 22;8(5):491. doi: 10.3390/cells8050491.

Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in n-acylethanolamines in mouse brain.

J Neurochem. 2017 Sep;142(5):662-671. doi: 10.1111/jnc.14067. Epub 2017 Jul 25.

Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.

Psychopharmacology (Berl). 2016 May;233(10):1879-88. doi: 10.1007/s00213-015-4140-6. Epub 2015 Nov 12.

The ventral pallidum as a critical region for fatty acid amide hydrolase inhibition of nausea-induced conditioned gaping in male Sprague-Dawley rats.

Neuropharmacology. 2019 Sep 1;155:142-149. doi: 10.1016/j.neuropharm.2019.05.031. Epub 2019 May 28.

Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.

Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G527-G538. doi: 10.1152/ajpgi.00148.2018. Epub 2019 Feb 21.

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

J Pharmacol Exp Ther. 2005 Apr;313(1):352-8. doi: 10.1124/jpet.104.078980. Epub 2004 Dec 3.

引用本文的文献

Aging-Associated Amyloid-β Plaques and Neuroinflammation in Bottlenose Dolphins () and Novel Cognitive Health-Supporting Roles of Pentadecanoic Acid (C15:0).

Int J Mol Sci. 2025 Apr 16;26(8):3746. doi: 10.3390/ijms26083746.

A Review on Phytochemical Constituents used as Current Treatment Strategies for Neurodegenerative Disease.

Antiinflamm Antiallergy Agents Med Chem. 2025;24(2):75-83. doi: 10.2174/0118715230310192240925165925.

Role of copper chelating agents: between old applications and new perspectives in neuroscience.

Neural Regen Res. 2025 Mar 1;20(3):751-762. doi: 10.4103/NRR.NRR-D-24-00140. Epub 2024 May 13.

Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer's drugs.

Neural Regen Res. 2023 Dec;18(12):2671-2672. doi: 10.4103/1673-5374.373685.

Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer's Disease.

Antioxidants (Basel). 2022 Aug 23;11(9):1631. doi: 10.3390/antiox11091631.

Can foods influence the onset and progress of neurodegenerative diseases?

Neural Regen Res. 2022 Nov;17(11):2443-2444. doi: 10.4103/1673-5374.335810.

A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).

Molecules. 2022 Jan 31;27(3):958. doi: 10.3390/molecules27030958.

The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.

J Alzheimers Dis. 2022;85(4):1601-1619. doi: 10.3233/JAD-215084.

Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases.

Foods. 2020 Dec 24;10(1):29. doi: 10.3390/foods10010029.

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors.

Int J Mol Sci. 2020 Sep 24;21(19):7026. doi: 10.3390/ijms21197026.

本文引用的文献

An innovative approach for the treatment of Alzheimer's disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions.

Neural Regen Res. 2019 Jan;14(1):43-45. doi: 10.4103/1673-5374.241043.

Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease.

Molecules. 2018 Aug 29;23(9):2182. doi: 10.3390/molecules23092182.

Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy.

Neural Regen Res. 2017 Aug;12(8):1256-1261. doi: 10.4103/1673-5374.213541.

Targeting Fatty-Acid Amide Hydrolase with Prodrugs for CNS-Selective Therapy.

ACS Chem Neurosci. 2017 Nov 15;8(11):2468-2476. doi: 10.1021/acschemneuro.7b00239. Epub 2017 Aug 18.

Endocannabinoid system in neurodegenerative disorders.

J Neurochem. 2017 Sep;142(5):624-648. doi: 10.1111/jnc.14098. Epub 2017 Jul 5.

New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge.

Neural Regen Res. 2017 Mar;12(3):405-406. doi: 10.4103/1673-5374.202942.

New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity.

Eur J Med Chem. 2017 Feb 15;127:379-397. doi: 10.1016/j.ejmech.2016.12.047. Epub 2016 Dec 24.

Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1166-1177. doi: 10.1016/j.bbrc.2016.08.043. Epub 2016 Aug 8.

Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.

Handb Exp Pharmacol. 2015;231:233-59. doi: 10.1007/978-3-319-20825-1_8.

Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175.

Eur J Med Chem. 2015 Jan 27;90:583-94. doi: 10.1016/j.ejmech.2014.11.044. Epub 2014 Nov 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验